Latest filing published 28 Jan 2015 for Sagent Pharmaceuticals, Inc., €658k.
Insider track record
No signal scores available.
Morgan Stanley Investment Management Inc: trading record in brief
Morgan Stanley Investment Management Inc is a declared insider of Sagent Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 24 filings; the first trade dates from 18 September 2013 and the latest from 27 January 2015.
The open-market record consists of 24 sales worth €21.6M, with no purchase. In 2015 alone, the filings show no purchases and 10 sales.
The newest entry dates from 28 January 2015: an open-market sale of €658k, in Sagent Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Morgan Stanley Investment Management Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,041 shares@ US$26.1158Common StockSEC:0001626176-15-000004:0
- 50,000 shares@ US$26.1895Common StockSEC:0001626176-15-000004:1
- 150,000 shares@ US$25.4876Common StockSEC:0001626176-15-000003:0
- 61,883 shares@ US$25.9023Common StockSEC:0001626176-15-000003:1
- 25,000 shares@ US$25.2373common stockSEC:0001626176-15-000002:0
- 44,316 shares@ US$25.2199Common StockSEC:0001626176-15-000002:1
- 75,000 shares@ US$25.10Common StockSEC:0001626092-15-000001:0
- 50,000 shares@ US$25.258Common StockSEC:0001626092-15-000001:1
- 50,000 shares@ US$25.4927Common StockSEC:0001626176-15-000001:0
- 50,000 shares@ US$25.5339Common StockSEC:0001626176-15-000001:1
- 47,826 shares@ US$20.2667Common StockSEC:0001585283-13-000027:0
- 50,000 shares@ US$20.7006Common StockSEC:0001585283-13-000026:0
- 40,020 shares@ US$20.3178Common StockSEC:0001585283-13-000026:1
- 31,300 shares@ US$20.5172common stockSEC:0001585283-13-000025:0
- 10,000 shares@ US$20.60common stockSEC:0001585283-13-000025:1
- 28,872 shares@ US$20.4637common stockSEC:0001585283-13-000025:2
- 25,000 shares@ US$20.3846common stockSEC:0001585283-13-000025:3
- 67,965 shares@ US$20.3679common stockSEC:0001585283-13-000024:0
- 14,693 shares@ US$21.4959common stockSEC:0001585283-13-000023:0
- 33,431 shares@ US$21.2184common stockSEC:0001585283-13-000023:1
- 91,714 shares@ US$21.9576Common StockSEC:0001585283-13-000022:0
- 27,843 shares@ US$21.4186Common StockSEC:0001585283-13-000022:1
- 49,043 shares@ US$22.8366Common StockSEC:0001585283-13-000021:0
- 39,842 shares@ US$22.148Common StockSEC:0001585283-13-000021:1
24 of 24 declarations
